LATTANZIO, Stefano
 Distribuzione geografica
Continente #
NA - Nord America 2.164
AS - Asia 1.488
EU - Europa 1.376
SA - Sud America 115
AF - Africa 19
Continente sconosciuto - Info sul continente non disponibili 4
Totale 5.166
Nazione #
US - Stati Uniti d'America 2.120
SG - Singapore 557
CN - Cina 441
UA - Ucraina 217
TR - Turchia 195
IE - Irlanda 191
SE - Svezia 176
GB - Regno Unito 167
FR - Francia 162
RU - Federazione Russa 152
VN - Vietnam 132
DE - Germania 96
BR - Brasile 94
IT - Italia 92
IN - India 76
FI - Finlandia 70
CA - Canada 24
HK - Hong Kong 18
PL - Polonia 17
BD - Bangladesh 14
MX - Messico 13
ES - Italia 9
IQ - Iraq 8
ZA - Sudafrica 8
AR - Argentina 6
AT - Austria 6
ID - Indonesia 6
JP - Giappone 6
PK - Pakistan 5
BE - Belgio 4
CL - Cile 4
MA - Marocco 4
NL - Olanda 4
SA - Arabia Saudita 4
BZ - Belize 3
EC - Ecuador 3
EU - Europa 3
JO - Giordania 3
PH - Filippine 3
VE - Venezuela 3
BY - Bielorussia 2
CO - Colombia 2
CZ - Repubblica Ceca 2
IL - Israele 2
KE - Kenya 2
KR - Corea 2
LT - Lituania 2
MY - Malesia 2
PA - Panama 2
PY - Paraguay 2
QA - Qatar 2
RO - Romania 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BO - Bolivia 1
BW - Botswana 1
CI - Costa d'Avorio 1
DK - Danimarca 1
DZ - Algeria 1
EG - Egitto 1
ET - Etiopia 1
GR - Grecia 1
HU - Ungheria 1
IR - Iran 1
KG - Kirghizistan 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
MN - Mongolia 1
MT - Malta 1
NI - Nicaragua 1
OM - Oman 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
UZ - Uzbekistan 1
Totale 5.166
Città #
Singapore 445
Chandler 262
Jacksonville 257
San Jose 230
Dublin 191
Ashburn 174
Beijing 138
Southend 132
Izmir 100
Dearborn 88
Princeton 85
Dallas 83
Nanjing 70
Los Angeles 63
Santa Clara 63
Wilmington 49
Cambridge 43
New York 42
The Dalles 39
Hanoi 37
Ho Chi Minh City 33
Altamura 26
Moscow 25
Tongling 25
Nanchang 24
Buffalo 21
Helsinki 19
Hong Kong 18
Munich 18
Kunming 17
Boardman 15
Washington 14
Hebei 13
Montreal 13
São Paulo 13
Ann Arbor 12
Atlanta 12
Augusta 12
Shenyang 12
Changsha 11
Jiaxing 11
Warsaw 11
Woodbridge 11
Brooklyn 9
Grevenbroich 8
Norwalk 8
Orem 8
Redondo Beach 8
San Mateo 8
Chieti 7
Frankfurt am Main 7
Hangzhou 7
Stockholm 7
Tianjin 7
Turku 7
Da Nang 6
Falls Church 6
London 6
Pescara 6
Seattle 6
Tokyo 6
Ankara 5
Bexley 5
Boston 5
Chennai 5
Denver 5
Hefei 5
Vancouver 5
Chicago 4
Haiphong 4
Jinan 4
Johannesburg 4
Lanzhou 4
Manchester 4
Mexico City 4
Milan 4
Mountain View 4
Nha Trang 4
Ningbo 4
Ninh Bình 4
Poplar 4
Querétaro 4
Rome 4
Tappahannock 4
Toronto 4
Chongqing 3
Detroit 3
Dong Ket 3
Erbil 3
Houston 3
Hải Dương 3
Mumbai 3
Phoenix 3
Shanghai 3
Wroclaw 3
Amman 2
Amsterdam 2
Baghdad 2
Belo Horizonte 2
Boscotrecase 2
Totale 3.247
Nome #
Pentraxin 3 and platelet activation in obese patients after gastric banding 179
Postprandial hyperglycemia is a determinant of platelet activation in early type 2 diabetes mellitus 179
Variability in the Recovery Rate of Platelet Cyclooxygenase Activity During Chronic Therapy With Low-Dose Aspirin in Type 2 Diabetes. 160
Platelet Cyclooxygenase Inhibition by Low-Dose Aspirin Is Not Reflected Consistently by Platelet Function Assays. Implications for Aspirin "Resistance" 152
Soluble CD40L in Mediterranean Spotted Fever: relation to oxidative stress and platelet activation 150
Inflammation, oxidative stress and platelet activation in aspirin-treated critical limb ischaemia: beneficial effects of iloprost. 145
Effects of atorvastatin and rosuvastatin on thromboxane-dependent platelet activation and oxidative stress in hypercholesterolemia. 143
Circulating endothelial progenitor cells and residual in vivo thromboxane biosynthesis in low-dose aspirin-treated polycythemia vera patients 141
Circulating endothelial progenitor cells and low-dose-aspirin-insensitive thromboxane biosynthesis in polycythemia rubra vera. 141
Determinants of thromboxane biosynthesis in patients with moderate to severe chronic kidney disease 141
Determinants of the Variability in the Recovery Rate of Platelet Cyclooxygenase Activity during Chronic Therapy with Low-Dose Aspirin in Type 2 Diabetes 140
Platelet cyclooxygenase inhibition by low-dose aspirin is not reflected consistently by platelet function assays. implications for aspirin 'resistance'. 140
The Recovery of Platelet Cyclooxygenase Activity Explains Interindividual Variability in Responsiveness to Low-Dose Aspirin in Patients With and Without Diabetes. 139
Circulating dickkopf-1 in diabetes mellitus: association with platelet activation and effects of improved metabolic control and low-dose aspirin. 137
Effects of high-amount-high-intensity exercise on in vivo platelet activation: Modulation by lipid peroxidation and AGE/RAGE axis 136
The contribution of cyclooxygenase-1 and -2 to persistent thromboxane biosynthesis in aspirin-treated essential thrombocythemia: implications for antiplatelet therapy. 135
Endogenous Secretory RAGE in Obese Women: Association with Platelet Activation and Oxidative Stress 135
Circulating Myeloid-Related Protein-8/14 is Related to Thromboxane-Dependent Platelet Activation in Patients With Acute Coronary Syndrome, With and Without Ongoing Low-Dose Aspirin Treatment. 127
Effects of atorvastatin and rosuvastatin on thromboxane-dependent platelet activation and oxidative stress in hypercholesterolemia. 126
Circulating endothelial progenitor cells and residual in vivo thromboxane biosynthesis in low-dose aspirin-treated polycythemia vera patients. 125
Thromboxane and prostacyclin biosynthesis in heart failure of ischemic origin: effects of disease severity and aspirin treatment. 124
LIGHT/TNFSF14 is increased in patients with type 2 diabetes mellitus and promotes islet cell dysfunction and endothelial cell inflammation in vitro 122
Platelet cyclooxygenase inhibition by low-dose aspirin is not reflected consistently by platelet function assays: implications for aspirin "resistance". 119
Enhanced Lipid Peroxidation and Platelet Activation as Potential Contributors to Increased Cardiovascular Risk in the Low-HDL Phenotype 116
Endogenous secretory rage in obese women: association with oxidative stress and platelet activation. Proc. 112° Congr. Naz. Soc It. Med. Interna, Roma, ottobre 2011, Int Emerg Med 6(S2): S186, 2011 112
Cellular Strategies for Separating GvHD from GvL in Haploidentical Transplantation 111
Postprandial hyperglycemia is an important determinant of platelet activation. evidence from biochemical measurements and pharmacological intervention with acarbose 111
Postprandial hyperglycemia is an important determinant of platelet activation in early type 2 diabetes mellitus. Evidence from biochemical measurements and pharmacological intervention with acarbose. 111
Determinants of Thromboxane-Dependent Platelet Activation in Heart Failure. 106
Effects of Acarbose on in Vivo Markers of Oxidative Stress and Platelet Activation in Early Type 2 Diabetes 105
Determinants of Platelet Activation in Heart Failure. 105
Thromboxane and prostacyclin biosynthesis in heart failure of ischemic origin: effects of disease severity and aspirin treatment. 104
Effects of Acarbose on in Vivo Markers of Oxidative Stress and Platelet Activation in Early Type 2 Diabetes. 103
Ultrarush venom immunotherapy and the lipoxin a4 inflammation resolution pathway 101
Soluble CD40L in Mediterranean Spotted Fever: Relation to oxidative stress and platelet activation. 100
Enhanced Lipid Peroxidation and Platelet Activation as Potential Contributors to Increased Cardiovascular Risk in the “Low-HDL” Phenotype 99
Thromboxane and prostacyclin biosynthesis in heart failure of ischemic origin: effects of disease severity and aspirin treatment. 99
Determinants of Platelet Activation in Heart Failure. 96
Soluble CD40L as an indicator of platelet Activation in Heart Failure 95
Oxidative Stress and Platelet Activation in Subjects with Moderate Hyperhomocysteinemia Due to MTHFR 677 C->T Polymorphism. 91
Stress-induced salivary cortisol secretion during hypobaric hypoxia challenge and in vivo urinary thromboxane production in healthy male subjects. 86
Oxidative Stress and Platelet Activation in Subjects with Moderate Hyperhomocysteinemia Due to MTHFR 677 C->T Polymorphism 86
Enhanced Lipid Peroxidation and Platelet Activation as Potential Contributors to Increased Cardiovascular Risk in the “Low-HDL” Phenotype. 79
Oxidative Stress and Platelet Activation in Subjects with Moderate Hyperhomocysteinemia Due to MTHFR 677 C->T Polymorphism. 75
Totale 5.327
Categoria #
all - tutte 19.214
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.214


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202151 0 0 0 0 0 0 0 0 0 43 3 5
2021/2022209 3 7 2 58 20 6 2 14 17 10 22 48
2022/2023655 46 97 46 67 64 127 33 45 101 7 9 13
2023/2024319 29 10 22 7 19 97 73 11 14 4 4 29
2024/2025836 53 176 148 15 19 35 12 17 61 21 123 156
2025/20261.554 132 69 132 194 218 102 329 68 199 111 0 0
Totale 5.327